Cargando...
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
The discovery of the immune checkpoint mechanism has contributed greatly to recent advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody ipilimumab was first approved as a therapeutic drug for malignant melanoma in the USA in 2011; since then, antiprogrammed cell...
Guardado en:
| Publicado en: | ESMO Open |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307608/ https://ncbi.nlm.nih.gov/pubmed/30622744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000455 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|